scholarly journals Undiagnosed dementia in primary care: a record linkage study

2020 ◽  
Vol 8 (20) ◽  
pp. 1-108 ◽  
Author(s):  
Clare F Aldus ◽  
Antony Arthur ◽  
Abi Dennington-Price ◽  
Paul Millac ◽  
Peter Richmond ◽  
...  

Background The number of people living with dementia is greater than the number with a diagnosis of dementia recorded in primary care. This suggests that a significant number are living with dementia that is undiagnosed. Little is known about this group and there is little quantitative evidence regarding the consequences of diagnosis for people with dementia. Objectives The aims of this study were to (1) describe the population meeting the criteria for dementia but without diagnosis, (2) identify predictors of being diagnosed and (3) estimate the effect of diagnosis on mortality, move to residential care, social participation and well-being. Design A record linkage study of a subsample of participants (n = 598) from the Cognitive Function and Ageing Study II (CFAS II) (n = 7796), an existing cohort study of the population of England aged ≥ 65 years, with standardised validated assessment of dementia and consent to access medical records. Data sources Data on dementia diagnoses from each participant’s primary care record and covariate and outcome data from CFAS II. Setting A population-representative cohort of people aged ≥ 65 years from three regions of England between 2008 and 2011. Participants A total of 598 CFAS II participants, which included all those with dementia who consented to medical record linkage (n = 449) and a stratified sample without dementia (n = 149). Main outcome measures The main outcome was presence of a diagnosis of dementia in each participant’s primary care record at the time of their CFAS II assessment(s). Other outcomes were date of death, cognitive performance scores, move to residential care, hospital stays and social participation. Results Among people with dementia, the proportion with a diagnosis in primary care was 34% in 2008–11 and 44% in 2011–13. In both periods, a further 21% had a record of a concern or a referral but no diagnosis. The likelihood of having a recorded diagnosis increased with severity of impairment in memory and orientation, but not with other cognitive impairment. In multivariable analysis, those aged ≥ 90 years and those aged < 70 years were less likely to be diagnosed than other age groups; those living with a spouse (odds ratio 2.38, 95% confidence interval 1.04 to 5.41) were more likely to be diagnosed than people living alone. The median time to diagnosis from first meeting the criteria for dementia was 3 years. Diagnosis did not affect survival or the probability of a move to residential care. Limitations People with moderate to severe dementia at baseline could not consent to record linkage. The small numbers in some groups limited power to detect effects. Conclusions The lack of relationship between severity of non-memory impairment and diagnosis may reflect low awareness of other symptoms of dementia. There remains little objective evidence for benefits of diagnosis for people with dementia. Future work Potential benefits of diagnosis can be realised only if effective interventions are accessible to patients and carers. Future work should focus on improving support for people living with cognitive impairment. Study registration National Institute for Health Research Clinical Research Network Central Portfolio Management System (CPMS 30655). Funding This project was funded by the National Institute for Health Research (NIHR) Health Services and Delivery Research programme and will be published in full in Health Services and Delivery Research; Vol. 8, No. 20. See the NIHR Journals Library website for further project information.

2018 ◽  
Vol 46 (3-4) ◽  
pp. 217-228 ◽  
Author(s):  
Mona Michelet ◽  
Knut Engedal ◽  
Geir Selbæk ◽  
Anne Lund ◽  
Guro Hanevold Bjørkløf ◽  
...  

Background/Aims: A timely diagnosis of dementia is important, and the Cognitive Function Instrument (CFI) is a newly developed instrument to screen for cognitive decline. The aim of this study was to evaluate the validity and internal consistency of the Norwegian version of the CFI. Methods: We included 265 participants with dementia, mild cognitive impairment (MCI), subjective cognitive impairment (SCI), and a reference group without subjective or assessed cognitive decline. The participants and their relatives answered the self- and proxy-rated versions of the CFI. Results: The Norwegian CFI had power to discriminate between people with dementia and with MCI, SCI, and the reference group. The proxy version had better power than the self-rated version in our participants (area under the curve [AUC] proxy-rated varying from 0.79 to 0.99, AUC self-rated varying from 0.56 to 0.85). Conclusion: The Norwegian CFI was found to be a useful, valid, and robust instrument.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Xiaoping Lin ◽  
Kasey Wallis ◽  
Stephanie A. Ward ◽  
Henry Brodaty ◽  
Perminder S. Sachdev ◽  
...  

Abstract Background Dementia was identified as a priority area for the development of a Clinical Quality Registry (CQR) in Australia in 2016. The Australian Dementia Network (ADNeT) Registry is being established as part of the ADNeT initiative, with the primary objective of collecting data to monitor and enhance the quality of care and patient outcomes for people diagnosed with either dementia or Mild Cognitive Impairment (MCI). A secondary aim is to facilitate the recruitment of participants into dementia research and trials. This paper describes the Registry protocol. Methods The ADNeT Registry is a prospective CQR of patients newly diagnosed with either dementia or MCI. Eligible patients will be identified initially from memory clinics and individual medical specialists (e.g., geriatricians, psychiatrists and neurologists) involved in the diagnosis of dementia. Participants will be recruited using either an opt-out approach or waiver of consent based on three key determinants (capacity, person responsible, and communication of diagnosis). Data will be collected from four sources: participating sites, registry participants, carers, and linkage with administrative datasets. It is anticipated that the Registry will recruit approximately 10,000 participants by the end of 2023. The ADNeT registry will be developed and implemented to comply with the national operating principles for CQRs and governed by the ADNeT Registry Steering Committee. Discussion The ADNeT Registry will provide important data on current clinical practice in the diagnosis, treatment and care of people with dementia and MCI in Australia as well as long-term outcomes among these people. These data will help to identify variations in clinical practice and patient outcomes and reasons underlying these variations, which in turn, will inform the development of interventions to improve care and outcomes for people with dementia and MCI.


2015 ◽  
Vol 108 (2) ◽  
pp. 296-305 ◽  
Author(s):  
Elizabeth Jean Comino ◽  
MD Fakhrul Islam ◽  
Duong Thuy Tran ◽  
Louisa Jorm ◽  
Jeff Flack ◽  
...  

Proceedings ◽  
2018 ◽  
Vol 2 (19) ◽  
pp. 1218
Author(s):  
Joseph Rafferty ◽  
Jonathan Synnott ◽  
Chris Nugent ◽  
Ian Cleland ◽  
Andrew Ennis ◽  
...  

The global population is ageing, as a consequence of this there will be a greater incidence of ageing related illnesses which cause cognitive impairment–such as Alzheimer’s disease. Within residential care homes, such cognitive impairment can lead to wandering of individuals beyond the boundaries of safety provided. This wandering, particularly in urban areas can be life threatening. This study introduces a novel solution to detect, and alert caregivers of, egress of at-risk inhabitants of a care home. This solution operates through a combination of wearable Bluetooth beacons and beam-formed listening devices. In an evaluation process involving 275 egress events, this solution proved to offer accurate operation with no incidence of false positives. Notably, this solution has been deployed within a real residential care home environment for over 12 months. Proposed future work discusses improvements to this solution.


2017 ◽  
Vol 13 (7S_Part_23) ◽  
pp. P1108-P1109
Author(s):  
Katharina Brueggen ◽  
Martin Dyrba ◽  
Ingo Kilimann ◽  
Wolfgang Hoffmann ◽  
Jochen René Thyrian ◽  
...  

2007 ◽  
Vol 24 (2) ◽  
pp. 108-116 ◽  
Author(s):  
C. Bamford ◽  
M. Eccles ◽  
N. Steen ◽  
L. Robinson

2015 ◽  
Vol 100 (12) ◽  
pp. 1115-1122 ◽  
Author(s):  
Thomas P C Chu ◽  
Anjali Shah ◽  
David Walker ◽  
Michel P Coleman

ObjectiveTo describe the age pattern and temporal evolution of symptoms and signs of intracranial tumours in children and young adults before diagnosis.Design and settingA record linkage study using population-based data from the National Cancer Registry, linked to Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES).Patient cohortPatients aged 0–24 years when diagnosed with a primary intracranial tumour between 1989 and 2006 in England.MethodsLinked records of relevant symptoms and signs in primary care and hospitals were extracted from CPRD (1989–2006, 181 patients) and HES (1997–2006, 3959 patients). Temporal and age-specific changes in presentation rates before diagnosis of an intracranial tumour, for each of eight symptom groups, were estimated in generalised additive models.ResultsAll symptoms presented with increasing frequency until eventual diagnosis. The frequency of presentation of raised intracranial pressure (ICP) to hospitals rose rapidly to 36.4 per 100 person-months (95% CI 34.6 to 38.4) in the final month before diagnosis in the entire cohort. Clinical features in primary care were less specific: the main features were visual disturbance (rate: 0.49 per 100 person-months; 95% CI 0.33 to 0.72) in newborns to 4-year-olds, headache in 5-year-olds to 11-year-olds (0.64; 0.47 to 0.88), 12-year-olds to 18-year-olds (1.59; 1.21 to 2.08) and 19-year-olds to 24-year-olds (2.44; 1.71 to 3.49). The predominant features at hospital admission were those of raised ICP: between 1.17 per 100 person-months (95% CI 1.08 to 1.26) in newborns to 4-year-olds and 0.77 (0.67 to 0.88) in 19-year-olds to 24-year-olds.ConclusionsNon-localising symptoms and signs were more than twice as common as focal neurological signs. An intracranial tumour should be considered in patients with relevant symptoms that do not resolve or that progress rapidly.


2015 ◽  
Vol 63 (9) ◽  
pp. 1953-1955 ◽  
Author(s):  
Raphael Goldacre ◽  
David Yeates ◽  
Michael J. Goldacre ◽  
Tiarnan D. L. Keenan

BMJ ◽  
1996 ◽  
Vol 313 (7061) ◽  
pp. 860-861 ◽  
Author(s):  
T M MacDonald ◽  
A D McMahon ◽  
I C Reid ◽  
G W Fenton ◽  
D G McDevitt

2021 ◽  
Vol 15 (1) ◽  
pp. 28-40
Author(s):  
Sónia Rolland Sobral ◽  
Margarida Sobral

ABSTRACT. Many studies have found that non-pharmacological interventions, such as cognitive stimulation (CS), can benefit people with dementia (PWD) or with mild cognitive impairment (MCI). The use of the computerized cognitive stimulation (CCS) had proven to be an ally to those who want to detect and mitigate this disease. Objective: The purpose of this paper was to analyze the scientific production in CCS in PWD or with MCI in journals indexed in Clarivate Analytics’ Web of Science and Elsevier’s Scopus since 2000. Methods: Data collected from Web of Science and Scopus during 2000–2019. Results: The data show that dementia research is exponentially developing following the evolution of widespread use of computer science. As such, this article was of enormous importance doing a bibliometric analysis of what has been done in the area since the beginning of this century. The search terms identified 61 papers related to the use of computers applied to CS in PWD or MCI, and the International Journal of Geriatric Psychiatry and Journal of Alzheimer’s Disease had the largest number of publications. The most cited article was the Faucounau et colleagues. Major research’ countries are United Kingdom, Spain and United States. Conclusions: The findings in these papers were analysed to find recommendations for future work in this area. The CCS has been increasingly used as an intervention tool for PWD or MCI, and there still seems to be a possibility for evolution in good quality publications.


Sign in / Sign up

Export Citation Format

Share Document